Value-based care and early palliative care are strategies to mitigate rising cancer treatment costs due to longer patient ...
A growing body of evidence shows that pediatric cardiology remains stuck in the first 2 generations of health equity research ...
Prioritizing education and shared decision-making can help patients with newly diagnosed heart failure feel less overwhelmed, ...
Pretreatment eosinophilia in NSCLC patients is associated with increased immune-related adverse events and reduced progression-free survival when treated with ICIs. The review included 11 ...
Navar presented the results of the phase 3 CORALreef Lipids trial, evaluating the oral PCSK9 inhibitor enlicitide in adult ...
Sotatercept (Winrevair; Merck) is enhancing treatment for patients with pulmonary arterial hypertension (PAH), explained ...
Navar A. Efficacy and safety of enlicitide, an oral PCSK9 inhibitor, for lowering LDL cholesterol in adults with or at-risk for ASCVD: the phase 3 CORALreef lipids trial. Presented at: AHA 2025 ...
Efficacy and safety of subcutaneous self-administered gefurulimab in generalized myasthenia gravis: topline results from a ...
Panelists discuss how accurate and early diagnosis remains one of the most difficult challenges in schizophrenia care. Many ...
A national survey found 13.1% of US youths use generative AI for mental health advice, with higher usage among those aged 18 to 21. Most users found AI advice helpful, but Black respondents were less ...
Older adults face unique barriers in hypertension management, including comorbidities, mobility limitations, and medication adherence challenges, impacting digital health tool effectiveness. Trials ...
A new option is now approved to treat adults living with high-risk smoldering multiple myeloma (MM). 1 The FDA has greenlit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results